Nathan Rich
Stock Analyst at Goldman Sachs
(1.02)
# 3,724
Out of 4,900 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $14.92 | +40.75% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $152.86 | +28.22% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $15.92 | +88.44% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.27 | -3.26% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $19.81 | -11.66% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $221.90 | +73.50% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $14.61 | -4.18% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $16.04 | -31.42% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $192.81 | +16.70% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $526.66 | +23.42% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $63.94 | +37.63% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $13.26 | -9.50% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $70.69 | +20.24% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $8.93 | +23.18% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $214.61 | +56.10% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $291.71 | +83.40% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $14.92
Upside: +40.75%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $152.86
Upside: +28.22%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $15.92
Upside: +88.44%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.27
Upside: -3.26%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $19.81
Upside: -11.66%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $221.90
Upside: +73.50%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $14.61
Upside: -4.18%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $16.04
Upside: -31.42%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $192.81
Upside: +16.70%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $526.66
Upside: +23.42%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $63.94
Upside: +37.63%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $13.26
Upside: -9.50%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $70.69
Upside: +20.24%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $8.93
Upside: +23.18%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $214.61
Upside: +56.10%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $291.71
Upside: +83.40%